This evidence prompted us to investigate signal transduction pathways crucial in the crosstalk between tumor cells and stroma, such as TGF-β and PAR-2 signalling, notoriously involved in pro-fibrotic/pro-inflammatory process in pancreatic cancer [35], as inducers of resistance to GEM/NAB. The gene discussed is F2RL1; the disease is pancreatic neoplasm.